Cartesian Therapeutics Inc
RNACLatest QuantConomy context for RNAC: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Cartesian Therapeutics Inc
QuantConomy has a structured record for RNAC. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- RNAC
- Name
- Cartesian Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- fmp alphavantage alpaca sec nasdaq
Recent signals for RNAC
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Mar 9, 12:00 AM | RNAC filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-03-09. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| reg fd disclosure | neutral | 70 | Jun 9, 11:20 AM | RNAC filed 8-K: Regulation FD Disclosure - 1 material event - [strong neutral signal] |
| material agreement | bullish | 95 | May 26, 11:10 AM | RNAC filed 8-K: Material Definitive Agreement, Direct Financial Obligation, Unregistered Sales of Equity - 5 material events - [very strong bullish signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| RNAC | NASDAQ | fmp | Cartesian Therapeutics, Inc. |
| RNAC | NASDAQ | alphavantage | Cartesian Therapeutics Inc |
| RNAC | NASDAQ | alpaca | Cartesian Therapeutics, Inc. Common Stock |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Hoge Elizabeth | Insider | exercise | 758,001 | — | — | 4 on EDGAR |
| Apr 2, 2026 | Kalayoglu Murat | Insider | exercise | 758,001 | — | — | 4 on EDGAR |
| Mar 13, 2026 | Singer Michael | Insider | gift | 6,555 | $0.00 | $0 | 4 on EDGAR |
| Jan 6, 2026 | Brunn Carsten | President and CEO | sale | 23,766 | $6.82 | $162,077 | 4 on EDGAR |
| Jan 6, 2026 | Davis Blaine | Chief Financial Officer | sale | 10,591 | $6.82 | $72,227 | 4 on EDGAR |
| Jan 6, 2026 | Miljkovic Milos | Chief Medical Officer | sale | 3,573 | $6.82 | $24,367 | 4 on EDGAR |
| Jan 2, 2026 | Davis Blaine | Chief Financial Officer | grant | 37,000 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | SPRINGER TIMOTHY A | Insider | grant | 2,600 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | BARABE TIMOTHY C | Insider | grant | 2,600 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | ZENNER PATRICK J | Insider | grant | 2,600 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Kalayoglu Murat | Insider | grant | 2,600 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Singer Michael | Insider | grant | 2,600 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Malik Kemal | Insider | grant | 2,600 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Miljkovic Milos | Chief Medical Officer | grant | 27,000 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | DeSilva Nishan M | Insider | grant | 2,600 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Seymour June Ann | Chief Accounting Officer | grant | 6,500 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | English Emily | Chief Operations Officer | grant | 24,000 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Brunn Carsten | President and CEO | grant | 143,200 | $0.00 | $0 | 4 on EDGAR |
| Dec 30, 2025 | English Emily | Chief Operations Officer | exercise | 7,500 | $3.30 | $24,750 | 4 on EDGAR |
| Dec 4, 2025 | BARABE TIMOTHY C | Insider | purchase | 30,000 | $6.86 | $205,797 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query RNAC context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access